Identification of a crocodylian β-defensin variant from Alligator mississippiensis with antimicrobial and antibiofilm activity.
Biofilms
Host defense peptides
Immunomodulation
Reptiles
β-Defensins
Journal
Peptides
ISSN: 1873-5169
Titre abrégé: Peptides
Pays: United States
ID NLM: 8008690
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
18
01
2021
revised:
30
03
2021
accepted:
31
03
2021
pubmed:
19
4
2021
medline:
9
2
2022
entrez:
18
4
2021
Statut:
ppublish
Résumé
β-defensin host defense peptides are important components of the innate immune system of vertebrates. Although evidence of their broad antimicrobial, antibiofilm and immunomodulatory activities in mammals have been presented, β-defensins from other vertebrate species, like crocodylians, remain largely unexplored. In this study, five new crocodylian β-defensin variants from Alligator mississippiensis and Crocodylus porosus were selected for synthesis and characterization based on their charge and hydrophobicity values. Linear peptides were synthesized, folded, purified and then evaluated for their antimicrobial and antibiofilm activities against the bacterial pathogens, Salmonella enterica serovar Typhimurium, Staphylococcus aureus, Enterobacter cloacae and Acinetobacter baumannii. The Am23SK variant (SCRFSGGYCIWNWERCRSGHFLVALCPFRKRCCK) from A. mississippiensis displayed promising activity against both planktonic cells and bacterial biofilms, outperforming the human β-defensin 3 under the experimental conditions. Moreover, Am23SK exhibited no cytotoxicity towards mammalian cells and exerted immunomodulatory effects in vitro, moderately suppressing the production of proinflammatory mediators from stimulated human bronchial epithelial cells. Overall, our results have expanded the activity landscape of crocodylian and reptilian β-defensin in general.
Identifiants
pubmed: 33865931
pii: S0196-9781(21)00057-7
doi: 10.1016/j.peptides.2021.170549
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
DEFB103A protein, human
0
Immunomodulating Agents
0
beta-Defensins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
170549Subventions
Organisme : CIHR
ID : FDN-154287
Pays : Canada
Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.